The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Regional differences in efficacy/safety/biomarkers in a randomised study of axitinib in 2nd line patients (pts) with advanced hepatocellular carcinoma (HCC).
 
Masatoshi Kudo
Honoraria - Ajinomoto; Bayer; Eisai; Kaken Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Chugai Pharma; Kowa; Taiho Pharmaceutical
Research Funding - Bayer; Bristol-Myers Squibb; Chugai Pharma; Kowa; Lilly; Novartis; Pfizer; Taiho Pharmaceutical
 
Joong-Won Park
Honoraria - Bayer; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb
 
Shuntaro Obi
No Relationships to Disclose
 
Shukui Qin
No Relationships to Disclose
 
Eric Assenat
Consulting or Advisory Role - Bayer; Ipsen; Novartis; Sanofi
Travel, Accommodations, Expenses - Bayer; Celgene; Novartis
 
Yoshiko Umeyama
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Debasis Chakrabarti
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Olga Valota
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Yosuke Fujii
Employment - Pfizer
 
Jean-Francois Martini
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
Patents, Royalties, Other Intellectual Property - Pfizer
 
James Andrew Williams
Employment - Pfizer; Roche
Stock and Other Ownership Interests - Pfizer; Roche
 
Yoon-Koo Kang
Consulting or Advisory Role - Lilly/ImClone; Novartis; Ono Pharmaceutical; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Bayer; Novartis; Roche/Genentech